课题基金 / 基金详情

项目摘要

项目成果

JOHN R DAVID的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In response to antigenic or mitogenic stimulation, lymphocytes secrete an array of meditors, known as lymphokines which exert profound effects on cells of the immune system. Macrophages play important roles in the initiation of immune responses and in host defense and these functions are under the control of a variety of lymphokines. Migration inhibitory factor (MIF), a lymphokine that inhibits the migration of macrophages is one of the lymphokines that correlates especially well with cellular immune responses. Until now, the lack of pure MIF precluded the determination of its physical and biological properties. We have recently isolated and sequenced a cDNA encoding a human MIF, MIF-1 (additional independent clones have been isolated but not yet examined in detail). It will allow the characterization of its gene and protein structure as well as facilitate the elucidation of its biological activities. The proposed work aims to investigate the structure of MIF-1 gene using the cloned MIF-cDNA as a probe to screen a human genomic library. Positive clones will be selected for analysis of intron/exon junctions and 5' and 3' regions of the gene and for mapping of the exons. The proposed work plans to purify recombinant MIF-1 using gel filtration, Phenyl-Sepharose chromatography, isoelectric focusing, and reverse phase high pressure liquid chromatography and to produce monoclonal antibodies to recombinant MIF-1 using established methods. This study further aims to investigate the effects of recombinant MIF-1 on cultured macrophages and the interactions of MIF-1 with other lymphokines that affect macrophages. The role of MIF in host defense and in cellular immunity will be delineated by monitoring antileishmanial activity and tumoricidal activity of macrophages treated with MIF alone or in combination with other lymphokines., This study also includes the analysis of the additional cDNA clones encoding different MIF species in order to determine their DNA sequences, to characterize the corresponding MIF proteins, to examine their bioactivities, and to correlate the production of specific MIF species in response to different antigenic stimulation at the level of mRNA.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1084/jem.166.5.1436
发表时间: 1987-11-01
期刊: The Journal of experimental medicine
影响因子: --
作者: [Weiser WY, Van Niel A, Clark SC, David JR, Remold HG]
通讯作者: Remold HG
Recombinant human migration inhibitory factor has adjuvant activity.
重组人迁移抑制因子具有佐剂活性。
DOI: 10.1073/pnas.89.17.8049
发表时间: 1992
期刊: Proceedings of the National Academy of Sciences of the United States of America
影响因子: 11.1
作者: [Weiser,WY, Pozzi,LM, Titus,RG, David,JR]
通讯作者: David,JR
Inhibition of growth of Mycobacterium avium in murine and human mononuclear phagocytes by migration inhibitory factor.
通过迁移抑制因子抑制鼠和人单核吞噬细胞中鸟分枝杆菌的生长。
DOI: 10.1128/iai.61.1.338-342.1993
发表时间: 1993
期刊: Infection and immunity
影响因子: 3.1
作者: [Orme,IM, Furney,SK, Skinner,PS, Roberts,AD, Brennan,PJ, Russell,DG, Shiratsuchi,H, Ellner,JJ, Weiser,WY]
通讯作者: Weiser,WY
DOI: 10.4049/jimmunol.150.5.1908
发表时间: 1993-03
期刊: Journal of immunology
影响因子: 4.4
作者: [F. Cunha;W. Weiser;J. David;D. Moss;S. Moncada;F. Liew]
通讯作者: F. Cunha;W. Weiser;J. David;D. Moss;S. Moncada;F. Liew
RECOMBINANT MIF AS AN ADJUVANT FOR HIV ANTIGENS
  • 批准号:
    2068228
  • 项目类别:
  • 资助金额:
    $20.35万
  • 财政年份:
    1992
  • 负责人:
    JOHN R DAVID
  • 依托单位:
RECOMBINANT MIF AS AN ADJUVANT FOR HIV ANTIGENS
  • 批准号:
    3548034
  • 项目类别:
  • 资助金额:
    $20.17万
  • 财政年份:
    1992
  • 负责人:
    JOHN R DAVID
  • 依托单位:
RECOMBINANT MIF AS AN ADJUVANT FOR HIV ANTIGENS
  • 批准号:
    3548033
  • 项目类别:
  • 资助金额:
    $19.61万
  • 财政年份:
    1992
  • 负责人:
    JOHN R DAVID
  • 依托单位:
AMERICAN SOCIETY FOR TROPICAL MEDICINE AND HYGIENE
  • 批准号:
    2066014
  • 项目类别:
  • 资助金额:
    $0.5万
  • 财政年份:
    1991
  • 负责人:
    JOHN R DAVID
  • 依托单位: